Marker Therapeutics Inc (MRKR)

[ridinbulls]

Nice find poods! This patient had 16 months of Folfirinox followed by the same maintenance for the next year. That puts things in perspective!

Article Abstract:

“Metastatic pancreatic adenocarcinoma confers a poor prognosis. Even with recent treatments, complete response of the disease is still very rare. In this case report, we present the case of a 67-yearold male with metastatic pancreatic adenocarcinoma who achieved a complete response lasting for more than three years after receiving induction chemotherapy with FOLFIRINOX for 16 months followed by same regimen maintenance for one year. Therefore, this evidence-based approach is recommended for highly selected patients with sustained responses to chemotherapy.”